Alphatec this week announced it appointed Dave Demski and Keith Valentine to its board. Demski is the former director and CEO of Globus Medical, which completed its merger with NuVasive in September. He was appointed as an independent director to Alphatec’s board. Valentine is the former CEO of Orthofix, and will become a special advisor […]
Spine
Alphatec plans launch of Calibrate LTX lateral expandable implant
Alphatec this week announced plans to launch the Calibrate LTX lateral expandable implant system at the 2023 NASS Annual meeting, taking place at the Los Angeles Convention Center, October 18-21. Carlsbad, California-based Alphatec designed the system to better achieve alignment goals with precise lordosis control and disc height restoration. “ATEC is uniquely dedicated to improving […]
FDA approves next-gen intrathecal drug delivery system from Medtronic
Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity. The targeted drug delivery (TDD) system alleviates symptoms by delivering medication directly to the fluid surrounding the spinal cord. SynchroMed III builds upon […]
J&J’s DePuy Synthes wins FDA clearance for TriAltis tech
Johnson & Johnson MedTech announced today that its DePuy Synthes unit won FDA 510(k) clearance for two TriAltis technologies. The FDA cleared the company’s TriAltis Spine system and the TriAltis navigation-enabled instruments. TriAltis Spine is a next-generation posterior thoracolumbar pedicle screw system. It offers a comprehensive implant portfolio and advanced instrumentation for integration with enabling […]
How Onward uses spinal cord stimulation — and perhaps BCI — to restore movement
The brain-computer interface space has taken medtech by storm. This novel approach from Onward has the potential to bring it to another level. Several companies are developing brain-computer interfaces (BCIs), many of which offer people with paralysis a chance to control external devices with their mind. Onward, a Dutch medtech company, develops technology that could […]
Augmedics taps former Medtronic AI expert as new VP of R&D
Augmedics announced today that it appointed former Medtronic leader Dr. Tal Davidson as its VP of research & development. Davidson most recently served as artificial intelligence (AI) research director site lead for Medtronic’s Visionsense. The medtech giant’s R&D site leads the development of intraoperative visualization and AI opportunities in minimally invasive surgery. News of Davidson’s […]
FDA grants IDE for ZimVie Mobi-C hybrid arthroplasty, fusion study
ZimVie announced today that it received FDA investigational device exemption (IDE) to conduct a study of its Mobi-C. The study evaluates the Mobi-C cervical disc in hybrid use. Patients in the study receive simultaneous cervical disc arthroplasty (CDA) and anterior cervical discectomy and fusion (ACDF) at adjacent levels between C3 and C7. ZimVie says the […]
Relievant Medsystems unveils Intracept simulation training program
Relievant Medsystems announced today that it released its Intracept simulator system, a training platform for the Intracept procedure. Further progress for Relievant and Intracept follows Tuesday’s major news of an agreement for Boston Scientific to acquire the company. Boston Scientific officials went into further detail on their expectations for the Relievant deal at the company’s […]
Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M
Boston Scientific announced today that it entered into a definitive agreement to acquire Relievant Medsystems. The transaction includes an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for chronic pain. The minimally invasive, FDA-cleared, […]
Aurora Spine launches SiLO TFX MIS sacroiliac joint fixation system
Aurora Spine (OTCQB:ASAPF) announced today that it began the full commercial release of its SiLO TFX MIS system. Carlsbad, California-based Aurora Spine designed the device for minimally invasive sacroiliac joint fixation. It treats conditions including sacroiliac joint disruptions and degenerative sacroiliitis. SiLO TFX includes a transfixing cone, an ilium screw, a sacrum screw and associated […]
Analysts downgrade Orthofix after the company terminates executives with cause
Orthofix today announced a slew of executive changes after terminating its CEO, CFO and chief legal officer with cause. Shares of OFIX sank nearly 25% at $14.06 apiece in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — fell nearly 1%. The Lewisville, Texas-based company’s […]